Core Viewpoint - The resignation of the chairman of Western Pastoral has raised concerns about the company's ongoing significant losses and the impact of a new controlling shareholder on its strategic direction [1][2]. Group 1: Company Performance - In 2024, Western Pastoral reported a significant decline in performance, with revenue of 938 million yuan, a year-on-year decrease of 16.46%, and a net loss of 119 million yuan, down 84.92% year-on-year [2][3]. - The company's revenue continued to decline in the first quarter of 2025, with 187 million yuan in revenue, a 20.87% decrease year-on-year, and a net loss of 9.81 million yuan, a 129.95% increase in losses year-on-year [2]. - During the tenure of the former chairman, the company's performance showed a trend of initial stability followed by decline, with revenue increasing from 820 million yuan in 2020 to 1.325 billion yuan in 2022, but net profit remained low [2][3]. Group 2: Industry Context - The dairy industry has been in a downturn for over three years, with an oversupply situation contributing to Western Pastoral's ongoing losses. The price of raw milk has been declining since September 2021, leading to significant losses in the industry [4]. - In 2024, the total production of raw milk was 40.79 million tons, a year-on-year decrease of 2.8%, indicating a challenging environment for dairy producers [4]. Group 3: Shareholder Changes - In September 2024, Western Pastoral changed its controlling shareholder, with the previous state-owned shareholder transferring its shares to Xinjiang Tiande Biological Co., which now holds 41.82% of the company [5]. - Despite the change in controlling shareholder, the actual controller of Western Pastoral remains unchanged, and the company stated that the chairman's resignation would not affect its strategic direction [5][6]. - Following the change in control, foreign institutional investors, including Morgan Stanley, began to increase their holdings in Western Pastoral, indicating a potential positive outlook for the dairy sector [6][7].

新疆西部牧业股份有限公司董事会 2025 年 7 月 10 日 1 附件： 证券代码：300106 证券简称：西部牧业 公告编号：临 2025-033 新疆西部牧业股份有限公司 关于选举董事长的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 新疆西部牧业股份有限公司（以下简称"公司"）于 2025 年 7 月 10 日召开第四届董事会第十七次会议，审议通过了《关于选举公 司第四届董事会董事长的议案》，选举刘羽先生（简历详见附件）为 公司第四届董事会董事长，任期自本次董事会审议通过之日起至第四 届董事会任期届满之日止。 根据公司《章程》的规定，董事长为公司的法定代表人。因此， 公司法定代表人变更为刘羽先生。公司将按照有关规定尽快完成变更 登记手续。 特此公告。 刘羽先生简历 刘羽先生，1982 年 11 月出生，中国国籍，中共党员，无境外永 久居留权，本科学历。2019 年 3 月至 2021 年 1 月任新疆生产建设兵 团第八师 150 团党委常委、副团长；2021 年 1 月至 2025 年 6 月任新 疆生产建设兵团第八师石河子市农业农村局党组成员、 ...

证券代码：300106 证券简称：西部牧业 公告编号：临2025-032 新疆西部牧业股份有限公司 第四届董事会第十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 新疆西部牧业股份有限公司（以下简称"公司"）于 2025 年 7 月 10 日北京时间 10:30 在公司二楼会议室，以现场结合通讯方式召开 了第四届董事会第十七次会议。会议通知于 2025 年 7 月 5 日以专人、 传真或邮件方式送达了全体董事，会议由董事刘羽先生召集并主持， 公司董事会成员在充分了解所审议事项的前提下，以现场结合通讯投 票方式对审议事项进行表决。本次会议在规定时间内应收回表决票 7 张，实际收回表决票 7 张，公司监事、高级管理人员列席了本次会议， 符合《公司法》和《公司章程》的有关规定。 同意选举刘羽先生为公司第四届董事会董事长，任期自本次董事 会审议通过之日起至第四届董事会任期届满之日止。 《关于选举公司董事长的公告》详见巨潮资讯网（www.cninfo. com.cn）。 本议案以 7 票同意，0 票弃权，0 票反对获得通过。 2.审议《关于选举第四届董 ...

Group 1 - Muyuan Foods expects a significant increase in net profit for the first half of 2025, projecting a profit of 10.5 billion to 11 billion yuan, representing a year-on-year growth of 924.6% to 973.39% [1][2] - The increase in profit is attributed to a rise in pig sales volume and a decrease in breeding costs compared to the previous year [2][3] Group 2 - TCL Technology anticipates a net profit of 1.8 billion to 2 billion yuan for the first half of 2025, reflecting a year-on-year increase of 81% to 101% [1][4] - The company's revenue is projected to be between 82.6 billion and 90.6 billion yuan, with a growth rate of 3% to 13% compared to the same period last year [1][4] - The semiconductor display business is expected to achieve a net profit exceeding 4.6 billion yuan, marking a growth of over 70% [3] Group 3 - TCL Zhonghuan is projected to incur a net loss of 4 billion to 4.5 billion yuan in the first half of 2025, compared to a loss of 3.064 billion yuan in the same period last year [4][5] - The loss is attributed to a decline in product prices and inventory impairment due to supply-demand imbalances in the industry [5] Group 4 - Shanghai Pharmaceuticals expects a net profit of 4.45 billion yuan for the first half of 2025, representing a year-on-year increase of approximately 52% [6] - The increase is partly due to the acquisition of a 10% stake in Shanghai Hutchison Pharmaceuticals, which has been consolidated into the financial statements [6] Group 5 - Northern Rare Earth anticipates a net profit of 900 million to 960 million yuan for the first half of 2025, indicating a year-on-year increase of 1882.54% to 2014.71% [7] - The growth is driven by improved production management, cost reduction, and increased sales of key products [7] Group 6 - Ganfeng Lithium expects a net profit of 600 million to 640 million yuan for the first half of 2025, reflecting a year-on-year increase of 100.73% to 114.12% [13] - The growth is attributed to significant revenue increases and effective cost control measures [13] Group 7 - Foster anticipates a net profit decrease of 49.05% for the first half of 2025, projecting a profit of 473 million yuan [17] - The decline is due to oversupply in the photovoltaic industry and intensified market competition, leading to lower sales prices [17]

西部牧业（300106）公告，公司董事会于2025年7月9日收到董事长李昌胜递交的书面辞职报告。李昌胜 因工作调动，辞去董事长、董事、战略委员会召集人职务。李昌胜原定任期至第四届董事会届满时止， 辞职后不再担任公司任何职务。李昌胜未直接或间接持有公司股份，其直系亲属也未持有公司股份。公 司将尽快完成董事长补选工作。 ...

证券代码：300106 证券简称：西部牧业 公告编号：临 2025-031 新疆西部牧业股份有限公司 关于董事长离任的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 新疆西部牧业股份有限公司（以下简称"公司"）董事会于 2025 年 7 月 9 日收到公司董事长李昌胜先生递交的书面辞职报告。李昌胜 先生因工作调动，申请辞去公司董事长、董事、战略委员会召集人职 务。李昌胜先生原定任期至公司第四届董事会届满时止，辞职后李昌 胜先生将不再担任公司任何职务。 鉴于李昌胜先生的辞职不会导致公司董事会人数低于法定最低 人数，不会影响公司董事会的正常运行，上述辞职报告自送达公司董 事会时生效，公司将按照法定程序尽快完成董事长的补选工作。 截至本公告披露日，李昌胜先生未直接或间接持有公司股份，其 直系亲属也未持有公司股份，不存在应当履行的股份锁定承诺。此外， 也不存在应当履行而未履行的公开承诺事项。 新疆西部牧业股份有限公司董事会 2025 年 7 月 9 日 1 李昌胜先生在任职期间，忠实、勤勉地履行了各项职责，本公司 及董事会对李昌胜先生在职期间为公司的发展所做出的 ...

2.本次股东大会不涉及变更以往股东大会已通过的决议。 3.本次股东大会以现场投票和网络投票相结合的表决方式召开。 证券代码：300106 证券简称：西部牧业 公告编号：临2025-030 新疆西部牧业股份有限公司 2025 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 特别提示： 1.本次股东大会无增加、变更、否决提案的情况。 一、会议召开和出席情况 新疆西部牧业股份有限公司（以下简称"公司"）2025 年第二次临 时股东大会于 2025 年 7 月 9 日 14:30 在新疆石河子市开发区北一东路 28 号公司办公楼二楼会议室召开。本次会议采取现场投票与网络投票结 合的表决方式，网络投票由公司委托深圳证券交易所交易系统和互联网 投票系统提供，其中，通过深圳证券交易所交易系统进行网络投票的时 间为2025年7月9日上午9:15－9:25，9:30－11:30，下午13:00－15:00； 通过深圳证券交易所互联网投票系统进行网络投票的时间为 2025 年 7 月 9 日上午 9:15 至下午 15:00。会议由公司董事会召集，董 ...

北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 国枫律股字[2025]A0355 号 致：新疆西部牧业股份有限公司（贵公司） 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司2025年第二次临时股东会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以下简称 "《股东会规则》"）、《律师事务所从事证券法律业务管理办法》（以下简称"《证 券法律业务管理办法》"）、《律师事务所证券法律业务执业规则（试行）》（以下简 称"《证券法律业务执业规则》"）等相关法律、行政法规、规章、规范性文件及《新 疆西部牧业股份有限公司章程》（以下简称"《公司章程》"）的规定，就本次会议的 召集与召开程序、召集人资格、出席会议人员资格、会议表决程序及表决结果等事宜， 出具本法律意见书。 对本法律意见书的出具，本所律师特作如下声明： 关于新疆西部牧业股份 ...

Group 1 - Shengde Xintai won a bid for a thermal power steel pipe project worth approximately 217 million yuan, accounting for 8.15% of its audited revenue for 2024 [1] - High-speed Electric's subsidiary won a project for the Shanghai-Nanjing-Hefei high-speed railway, with a bid amount of 71.76 million yuan [1] - Cangge Mining's subsidiary received a construction permit for a lithium-boron mining project, with a construction area of 106,900 square meters [2] Group 2 - China Electric Power Construction signed a mining transportation project contract in Guinea worth approximately 5.063 billion yuan, with a total duration of about 72 months [3] - Guobang Pharmaceutical's subsidiary completed the registration of an equity investment fund focusing on strategic emerging industries [4] - Deshi Co. obtained two invention patents related to oil and gas field development [5][26] Group 3 - Xue Tian Salt Industry expects a significant decrease in net profit for the first half of 2025, projecting a decline of 76.34% to 80.29% [6] - Rundu Co. received a drug registration certificate for moxifloxacin hydrochloride tablets, used for treating various bacterial infections [7] - China Nuclear Power reported a 15.65% increase in power generation in the first half of the year, with nuclear power generation up by 12.01% [8] Group 4 - Suqian Liansheng obtained two invention patents related to wastewater treatment methods [9] - Boshi Co. signed a 109 million yuan operation and maintenance service contract for solid product packaging [11] - *ST Sailong's subsidiary received a drug registration certificate for torasemide injection, used for various medical conditions [13] Group 5 - North Bay Port reported a 10.95% increase in cargo throughput for the first half of 2025, with container throughput also showing growth [14] - Kaiwei Te expects a revenue increase of 56.17% to 90.87% for the first half of 2025 [15] - Wankai New Materials plans to reduce production and conduct maintenance on 60,000 tons of PET capacity, affecting overall performance [16] Group 6 - Haiwang Bio's HW130 injection successfully completed Phase I clinical trials, showing good safety and tolerability [19] - Zhenai Meijia received a total of 22.8 million yuan in compensation for land acquisition, which will significantly impact its 2025 performance [20] - Changyuan Electric reported a 23.58% decrease in power generation in June, with a notable decline in thermal power generation [21] Group 7 - Shouxiangu's subsidiary completed the registration of two health food products [22] - Kailun Co. announced the resignation of its deputy general manager and board secretary [23] - Xibu Muye reported a 2.15% year-on-year increase in fresh milk production in June [24] Group 8 - Deshi Co. obtained two invention patents related to oil and gas field development [26] - Jingwei Huikai plans to acquire a 12.44% stake in Nuo Si Micro for 149 million yuan [27] - Electric Alloy completed the registration of its subsidiary in Mexico [29] Group 9 - Meinuohua expects a net profit increase of 142.84% to 174.52% for the first half of 2025 [30] - Guizhou Moutai repurchased approximately 3.38 million shares, accounting for 0.2692% of its total share capital [31][32] - Warner Pharmaceutical received approval for the listing application of a raw material drug for treating respiratory diseases [34] Group 10 - Yuan Dong Bio's independent director is under investigation for serious violations [35] - Dash Intelligent signed a contract for a smart project worth 11.88 million yuan [36] - Dayou Energy plans to transfer 586,500 tons of coal production capacity replacement indicators [37] Group 11 - Foton Motor reported a 150.96% increase in new energy vehicle sales in the first half of 2025 [39] - Renfu Pharmaceutical's shareholder plans to increase its stake by 1% to 2% [40] - Zongshen Power expects a net profit increase of 70% to 100% for the first half of 2025 [42] Group 12 - Yingboer plans to sell its wholly-owned subsidiary for 239 million yuan [44] - Changan Automobile reported a 1.59% increase in total vehicle sales in the first half of 2025 [46] - Fulian Precision signed a cooperation framework agreement with Sichuan Development Longmang [48] Group 13 - Nengte Technology plans to repurchase shares worth 300 million to 500 million yuan [50] - Longsoft Technology's controlling shareholder donated 3.43% of the company's shares [51] - Data Port's shareholders plan to reduce their holdings by up to 2% [52]

德邦证券股份有限公司 关于 新疆西部牧业股份有限公司收购报告书 之 2025 年第二季度持续督导报告 财务顾问 二〇二五年七月 1 声明 德邦证券股份有限公司接受新疆天得生物有限公司委托，担任其收购新疆西 部牧业股份有限公司之财务顾问。根据《上市公司收购管理办法》第七十二条， "在上市公司收购行为完成后 12 个月内，收购人聘请的财务顾问应当就上一季 度对上市公司影响较大的投资、购买或者出售资产、关联交易、主营业务调整以 及董事、监事、高级管理人员的更换、职工安置、收购人履行承诺等情况向派出 机构报告" 本财务顾问根据《上市公司收购管理办法》等规定，按照证券行业公认的业 务标准、道德规范，本着诚实信用、勤勉尽责的态度并经过审慎核查，结合 2025 年第二季度（2025 年 4 月 1 日至 2025 年 6 月 30 日）对上市公司影响较大的投 资、购买或出售资产、关联交易、主营业务调整以及董事、监事、高级管理人员 的更换、职工安置、信息披露义务人履行承诺等情况出具本报告。 本持续督导报告根据收购人及上市公司提供的相关材料编制，收购人及上市 公司均已向本财务顾问保证，其所提供的为出具本持续督导报告所依据的所有 ...